Respiratory News and Research

RSS

Gastric bypass surgery enhances energy expenditure

Gastric bypass surgery often leads to a sustained weight loss. Researchers at Sahlgrenska Academy have found part of the explanation: the operation enhances energy expenditure such that eating actually helps the person lose weight.

12 Aug 2015

McMaster research shows benefits of corticosteroid therapy for patients with pneumonia

McMaster University research, published online today by the Annals of Internal Medicine, has demonstrated the benefits of corticosteroid therapy for one of the most common serious medical conditions.

11 Aug 2015

Screening questionnaire helps anesthesia professionals identify SDB symptoms in children prior to surgery

Knowing which risks may come into play before or during surgery is especially important where children are concerned.

11 Aug 2015

Simple web-based programme to encourage handwashing reduces risk of respiratory tract infections

A web-based programme to encourage more frequent handwashing reduces the risk of catching and passing on respiratory tract infections to other household members, a randomised trial of more than 16,000 UK households published in The Lancet has found.

10 Aug 2015

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Mallinckrodt plc, a leading specialty biopharmaceutical company, and The Gores Group, a global investment firm, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Therakos, Inc. a leading immunotherapy company in a transaction valued at approximately $1.325 billion.

10 Aug 2015

Passionate kissing not the norm in most cultures, research finds

For generations, passionate kisses immortalized in movies, songs and the arts have served as a thermometer of romantic affection.

7 Aug 2015

Hill-Rom Holdings' revenue increases 19% to $475 million in third quarter 2015

Hill-Rom Holdings, Inc. announced financial results for its third quarter ended June 30, 2015 and updated its 2015 financial outlook. Adjusted earnings per diluted share of $0.62 increased 5 percent from $0.59 in the prior year, while reported earnings per diluted share of $0.33 decreased from $0.45. Adjustments to reported earnings are detailed in the reconciliation schedules provided.

7 Aug 2015

Pitt researchers figure out how to quantify beating action of cilia

Researchers at the University of Pittsburgh School of Medicine have figured out how to objectively quantify the beating action of cilia, the tiny, hair-like projections on cells that line nasal passages, the lungs and almost every other body tissue, according to a study published online today in Science Translational Medicine.

6 Aug 2015

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.

6 Aug 2015

BD reports adjusted revenues of $3.133 billion for third fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June 30, 2015, an increase of 45.2 percent over the prior-year period as reported, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues were $3.120 billion.

From BD (Becton, Dickinson and Company) 6 Aug 2015

Diaphragmatic pacing ’harmful’ in amyotrophic lateral sclerosis

Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis and respiratory insufficiency, show findings from a randomised controlled trial.

5 Aug 2015

Children increase parents’ risk for viral infection

The BIG LoVE (Utah Better Identification of Germs-Longitudinal Viral Epidemiology) study, led by scientists at the University of Utah School of Medicine, finds that each bundle of joy puts the entire household at increased risk for infection with viruses that cause colds, flu, and other respiratory illnesses.

5 Aug 2015

Missing follow-up visit to pulmonologist after COPD exacerbation increases risk for hospital readmission

Researchers have found the risk for hospital readmission to be nearly three times higher after COPD exacerbation if a follow-up visit to a pulmonologist is skipped.

5 Aug 2015

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Australian pharmaceutical company Pharmaxis Ltd and UK biotechnology company Synairgen plc today announced they have entered into a research collaboration to develop a selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) to treat the fatal lung disease idiopathic pulmonary fibrosis (IPF).

5 Aug 2015

Research finds no link between teen marijuana use and later mental health issues

Chronic marijuana use by teenage boys does not appear to be linked to later physical or mental health issues such as depression, psychotic symptoms or asthma, according to a study published by the American Psychological Association.

5 Aug 2015

Vaccine containing virus-like nanoparticles could be novel treatment option for RSV

A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University.

4 Aug 2015

Isis Pharmaceuticals, AstraZeneca to develop antisense therapies for cardiovascular, metabolic, renal diseases

AstraZeneca and Isis Pharmaceuticals, Inc. today announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases.

3 Aug 2015

New national survey finds lack of COPD knowledge among patients

In a new national survey of chronic obstructive pulmonary disease (COPD) patients, Health Union reveals a surprising lack of awareness of risk factors and knowledge of diagnosis stage among patients. Results demonstrate a severe impact on quality of life, employment, and ability to afford treatment.

30 Jul 2015

Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

Astellas today announced topline results from the Phase 3 ACTIVE study evaluating the efficacy and safety of intravenous (IV) and oral isavuconazole, commercially known as CRESEMBA (isavuconazonium sulfate), under development for adults with candidemia and other invasive Candida infections.

30 Jul 2015

UT Southwestern's Pulmonary Hypertension Program continues to grow in the U.S.

When Derrik Neal began having trouble breathing, he initially assumed it was because he was overweight. But after blacking out several times, he learned he had idiopathic pulmonary hypertension. Survival rates at the time he was diagnosed were five years or less - three or less if undetected.

30 Jul 2015

Respiratory News and Research

Gastric bypass surgery enhances energy expenditure

McMaster research shows benefits of corticosteroid therapy for patients with pneumonia

Screening questionnaire helps anesthesia professionals identify SDB symptoms in children prior to surgery

Simple web-based programme to encourage handwashing reduces risk of respiratory tract infections

Mallinckrodt subsidiary to acquire Therakos for $1.325 billion

Passionate kissing not the norm in most cultures, research finds

Hill-Rom Holdings' revenue increases 19% to $475 million in third quarter 2015

Pitt researchers figure out how to quantify beating action of cilia

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

BD reports adjusted revenues of $3.133 billion for third fiscal quarter 2015

Diaphragmatic pacing ’harmful’ in amyotrophic lateral sclerosis

Children increase parents’ risk for viral infection

Missing follow-up visit to pulmonologist after COPD exacerbation increases risk for hospital readmission

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Research finds no link between teen marijuana use and later mental health issues

Vaccine containing virus-like nanoparticles could be novel treatment option for RSV

Isis Pharmaceuticals, AstraZeneca to develop antisense therapies for cardiovascular, metabolic, renal diseases

New national survey finds lack of COPD knowledge among patients

Astellas reports topline results from isavuconazole Phase 3 study in candidemia and other invasive Candida infections

UT Southwestern's Pulmonary Hypertension Program continues to grow in the U.S.

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News